SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Hemispherx Biopharma, Inc.
(NYSE Amex Equities : HEB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading HEB News...
Health Technology » Biotechnology
GILDGilead Sciences, Inc.
AMGNAmgen Inc.
BIIBBiogen Inc.
CELGCelgene Corporation
ILMNIllumina, Inc.
REGNRegeneron Pharmaceuticals, Inc.
SRPTSarepta Therapeutics, Inc.
ALXNAlexion Pharmaceuticals, Inc.
INCYIncyte Corporation
VRTXVertex Pharmaceuticals Incorporated
CLVSClovis Oncology, Inc.
EXELExelixis, Inc.
BMRNBioMarin Pharmaceutical Inc.

Company Profile

Hemispherx Biopharma, Inc. is a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and the experimental immunotherapeutic/antiviral Ampligen. Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Ampligen includes application as a treatment for Chronic Fatigue Syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.